Interestingly, verapamil was able to mimic the anti-diabetic effects of genetic TXNIP deletion observed in mouse models of T1D and T2D again using STZ-induced and obesity-induced diabetic mice treated with or without oral verapamil (13). This evidence concerns the gene TXNIP and obesity disorder.